IDEAYA Biosciences Competitors and Similar CompaniesClear all
IDEAYA Biosciences's competitors and similar companies include Galectin Therapeutics and Signpath Pharma.
 Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. |  Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia. | ||
Founding Date | Founding Date 2015 | Founding Date 2001 | Founding Date 2006 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations South San Francisco, US HQ San Diego, US | Locations Norcross, US HQ | Locations Sandy, US HQ |
Employees | Employees 56 | Employees 717% increase | Employees 11 |
Valuation ($) | Valuation ($) 2.5 b | Valuation ($) 155.1 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($113.7m) (FY, 2025) | Net income ($30.8m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 140m | Total funding raised N/A | Total funding raised $ 5.3m |
For sources of this data, please see the company profile
View Company Profiles
Galectin Therapeutics
HQ
Norcross, US
Employees
7↑ 17% increase
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
View companySignpath Pharma
HQ
Sandy, US
Employees
11
SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.
View company